AMP-PNP tetralithium is a non-hydrolyzable ATP analog that inhibits KATP channels; it reduces the open probability of KATP channels and decreases single-channel currents by approximately 10% at high nucleotide concentrations (5–500 μM); it inhibits KATP channels in ventricular myocytes and pancreatic β-cells, both in the absence and presence of Mg²⁺ ions.